Anuradha Sehrawat, Ph.D. a molecular biologist with advanced degrees in Toxicological Sciences from Jamia Hamdard University, India. Dr. Sehrawat’s research expertise spans cellular and molecular biology, biochemistry, and toxicology, with a focus on gene therapy for a range of diseases; including diabetes (types 1 and 2), pancreatitis, and cancer. Presently, Dr. Sehrawat’s research is dedicated to developing new innovative bioanalytical methods for blood biomarkers in clinical settings. These methods aim to facilitate the early detection and diagnosis of Alzheimer’s disease, as well as identifying early pathological changes in the brain that may allow for preventive interventions. In her free time, Anu finds joy in practicing yoga, meditating, and reading.